drugset / Trial / NCT04466618
Endogenous GLP-1 Secretion on Islet Function in People With and Without Type 2 Diabetes
Phase 3
Completed
23 enrolled
Adrian Vella
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · collab
RandomizedParallel-groupOpen-labelBasic science
Summary
GLP-1 is a hormone made by the body that promotes the production of insulin in response to GLP-1 is produced within the islets expressing prohormone convertase 1/3eating. However, there is increasing evidence that this hormone might help support the body's ability to produce insulin when diabetes develops. The purpose of this study is to determine the effect of endogenous GLP-1 secretion on insulin secretion in people with and without type 2 diabetes.
Timeline
- Start
- 2021-04-15
- Primary completion
- 2022-12-15
- Completion
- 2022-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Avexitide | Peptide | — | — |
| Comparator | Heparin | Other / unclassified | — | — |
| Comparator | Intralipid | Other / unclassified | — | — |